Non-alcoholic fatty liver disease (NAFLD) affects up to one third of Australians and will likely become more prevalent with the global escalation of obesity. NAFLD is an umbrella term for a spectrum of liver disorders, ranging from simple steatosis (excess liver fat) to more serious liver diseases including non-alcoholic steatohepatitis, liver cirrhosis and liver cancer. NAFLD is a leading cause of chronic liver disease worldwide and independently leads to metabolic dysfunction including insulin resistance, type 2 diabetes and cardiovascular disease. It is now established that exercise is an effective therapy for reducing liver fat, even in the absence of weight loss. With a focus on clinical case studies, this professional development will explore the role of exercise in the management of NAFLD. It will present the latest evidence for exercise prescription across the spectrum of NAFLD severity and will address special considerations for the accredited exercise physiologist working in clinical practice.
The recording is of a webinar presented by ESSA on 29 June 2017.
Dr Shelley Keating is an NHMRC Early Career Fellow at the School of Human Movement and Nutrition Sciences, The University of Queensland. As an Accredited Exercise Physiologist, her research explores the role that exercise plays in the management of obesity and obesity-related chronic disease, with a focus on non-alcoholic fatty liver disease (NAFLD). Shelley completed her PhD at the University of Sydney in 2015, where her research demonstrated that liver and visceral fat can be reduced in obese individuals without weight loss and using exercise interventions that fall below current recommendations for obesity management. Shelley’s current research interests include the investigation of the optimal ‘dose’ of exercise for visceral and liver fat reduction, and the management of type 2 diabetes and non-alcoholic steatohepatitis. She was the recipient of the 2015 ESSA Tom Penrose Community Service Grant for her project ‘High intensity exercise for non-alcoholic steatohepatitis – is it safe, effective, and feasible in practice?’
|ESSA Student Member||$15.00|
Please see terms & conditions for registration type definitions
You will be provided all information to access this podcast within your registration confirmation email
Any Accredited Exercise Scientist or Accredited Exercise Physiologist
Audience Disclaimer: All accredited persons, regardless of any professional development completed/attended must refer to their accreditation’s Scope of Practice, and only treat/practice within the same.
Successful completion of an assessment, within 60 days is required to earn applicable CPD Point.
Or download the Manual Registration Form